论文部分内容阅读
直接末稍白细胞移动抑制试验(MIT-由特异的抗原刺激淋巴细胞后释放出可溶性中间物而抑制白细胞,主要是多形核白细胞的移动)是人体迟发性超敏反应的简易可靠的指征。本文报告以结核菌纯蛋白衍化物(PPD)作特异抗原来了解MIT与肺结核病人体内结核菌消长的关系。 32例新发现的痰涂片及培养阳性的肺结核病人每隔二周连续查痰(涂片及培养)三次。在治疗前及治疗后3、6及12周作MIT(按Soborg及Bendixen氏改良法,Acta Medica Scandin.,181:247,1967。)。按痰菌阴转速度不同,凡在治疗6周内阴转者属快速阴转,归为A组;若在治疗6周后仍阳性者属缓慢阴转,归为B组。有14例每
The direct terminal leukocyte mobilization inhibition test (MIT - release of soluble intermediates by specific antigens to stimulate lymphocytes to inhibit the movement of leukocytes, predominantly polymorphonuclear leukocytes) is a simple and reliable indication of delayed hypersensitivity in the human body . This article reports the tuberculosis pure protein derivative (PPD) as a specific antigen to understand the MIT and tuberculosis patients with the relationship between the growth and decline of TB. Thirty-two newly diagnosed sputum smear and culture-positive pulmonary tuberculosis patients were examined sputum (smear and culture) three times every two weeks. MIT was performed before treatment and at 3, 6 and 12 weeks after treatment (according to the Soborg and Bendixen’s Modified Act, Acta Medica Scandin., 181: 247, 1967). According to different sputum negative speed, where in the treatment of 6 weeks, the negative conversion is a fast negative conversion, classified as A group; if still positive after 6 weeks of treatment is a slow negative conversion, classified as B group. There are 14 cases each